| Cue integration and the perception of action in intentional binding N Wolpe, P Haggard, HR Siebner, JB Rowe Experimental brain research 229, 467-474, 2013 | 133 | 2013 |
| Ageing increases reliance on sensorimotor prediction through structural and functional differences in frontostriatal circuits N Wolpe, JN Ingram, KA Tsvetanov, L Geerligs, RA Kievit, RN Henson, ... Nature communications 7 (1), 13034, 2016 | 112 | 2016 |
| The medial frontal-prefrontal network for altered awareness and control of action in corticobasal syndrome N Wolpe, JW Moore, CL Rae, T Rittman, E Altena, P Haggard, JB Rowe Brain 137 (1), 208-220, 2014 | 94 | 2014 |
| Beyond the “urge to move”: objective measures for the study of agency in the post-Libet era N Wolpe, JB Rowe Frontiers in human neuroscience 8, 450, 2014 | 85 | 2014 |
| Activity and connectivity differences underlying inhibitory control across the adult life span KA Tsvetanov, Z Ye, L Hughes, D Samu, MS Treder, N Wolpe, LK Tyler, ... Journal of Neuroscience 38 (36), 7887-7900, 2018 | 68 | 2018 |
| Sex differences in the use of anticipatory brain activity to encode emotional events G Galli, N Wolpe, LJ Otten Journal of Neuroscience 31 (34), 12364-12370, 2011 | 53 | 2011 |
| Age-related reduction in motor adaptation: brain structural correlates and the role of explicit memory N Wolpe, JN Ingram, KA Tsvetanov, RN Henson, DM Wolpert, LK Tyler, ... Neurobiology of aging 90, 13-23, 2020 | 49* | 2020 |
| Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease C O’Callaghan, FH Hezemans, R Ye, C Rua, PS Jones, AG Murley, ... Brain 144 (8), 2513-2526, 2021 | 47 | 2021 |
| Seeing what you want to see: priors for one's own actions represent exaggerated expectations of success N Wolpe, DM Wolpert, JB Rowe Frontiers in Behavioral Neuroscience 8, 232, 2014 | 44 | 2014 |
| Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose N Wolpe, J Zhang, C Nombela, JN Ingram, DM Wolpert, JB Rowe Scientific Reports 8 (1), 15643, 2018 | 37 | 2018 |
| Apathy is associated with reduced precision of prior beliefs about action outcomes. FH Hezemans, N Wolpe, JB Rowe Journal of Experimental Psychology: General 149 (9), 1767, 2020 | 19 | 2020 |
| Time on timing: dissociating premature responding from interval sensitivity in Parkinson's disease J Zhang, C Nombela, N Wolpe, RA Barker, JB Rowe Movement Disorders 31 (8), 1163-1172, 2016 | 19 | 2016 |
| Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes FH Hezemans, N Wolpe, C O’Callaghan, R Ye, C Rua, PS Jones, ... PLoS Computational Biology 18 (5), e1010079, 2022 | 17 | 2022 |
| Prefrontal cortical connectivity mediates locus coeruleus noradrenergic regulation of inhibitory control in older adults A Tomassini, FH Hezemans, R Ye, KA Tsvetanov, N Wolpe, JB Rowe Journal of Neuroscience 42 (16), 3484-3493, 2022 | 16 | 2022 |
| The pre-supplementary motor area achieves inhibitory control by modulating response thresholds N Wolpe, FH Hezemans, CL Rae, J Zhang, JB Rowe cortex 152, 98-108, 2022 | 13 | 2022 |
| Alien limb in the corticobasal syndrome: phenomenological characteristics and relationship to apraxia DJ Lewis-Smith, N Wolpe, BCP Ghosh, JB Rowe Journal of Neurology 267, 1147-1157, 2020 | 13 | 2020 |
| Dopaminergic modulation of positive expectations for goal-directed action: evidence from Parkinson’s disease N Wolpe, C Nombela, JB Rowe Frontiers in psychology 6, 1514, 2015 | 13 | 2015 |
| Alien limb syndrome: A Bayesian account of unwanted actions N Wolpe, FH Hezemans, JB Rowe Cortex 127, 29-41, 2020 | 12 | 2020 |
| Disorders of volition from neurological disease: altered awareness of action in neurological disorders JB Rowe, N Wolpe The sense of agency. Oxford University Press, Oxford, 2014 | 10 | 2014 |
| Distinct components of cardiovascular health are linked with age-related differences in cognitive abilities DLO King, RN Henson, R Kievit, N Wolpe, C Brayne, LK Tyler, JB Rowe, ... Scientific Reports 13 (1), 978, 2023 | 4 | 2023 |
James RoweProfessor of Cognitive Neurology, Cambridge UniversityVerified email at mrc-cbu.cam.ac.uk
